What is iS Clinical?
iS Clinical, operating under Innovative Skincare, is dedicated to advancing skin health through scientifically developed, botanically based, and clinically proven skincare products. The company emphasizes ethical standards, proprietary formulas, and the use of cutting-edge technologies and ingredients. Their product development is guided by a team of pharmacologists, geneticists, biologists, and physicians, with a strong commitment to clean beauty, environmental consciousness, and animal welfare. Rigorous testing and independent clinical studies validate the efficacy of their offerings, aiming to enhance the physical and emotional well-being of consumers globally across all ages, genders, and skin types.
How much funding has iS Clinical raised?
iS Clinical has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for iS Clinical?
The recent major strategic investment indicates iS Clinical is poised for further expansion and innovation. This capital infusion will likely fuel advancements in research and development, potentially leading to new product lines or enhanced distribution channels. The company's focus on scientific rigor and clean beauty positions it favorably to capitalize on the growing demand for effective, ethically produced skincare solutions, reinforcing its enterprise-level standing in the competitive beauty industry.
See full iS Clinical company page
